Related Experiment Videos
Lexipafant inhibits postsurgical adhesion formation
Hedef Ozgün1, Mehmet Hakan Cevikel, Leyla Didem Kozaci
1Department of Surgery, Adnan Menderes University, Aydin, Turkey.
The Journal of Surgical Research
|April 2, 2002
Summary
Lexipafant, a platelet activating factor antagonist, effectively prevents peritoneal adhesion formation. This study found no significant impact on wound healing, suggesting its therapeutic potential in inflammatory conditions.
Area of Science:
- Biomedical research
- Inflammation and immunology
Background:
- Platelet-activating factor (PAF) antagonists are explored for inflammatory conditions.
- Lexipafant's role in peritoneal adhesion and wound healing requires investigation.
Purpose of the Study:
- To evaluate the efficacy of lexipafant in preventing peritoneal adhesion formation.
- To assess the effect of lexipafant on wound healing processes.
Main Methods:
- 48 Wistar albino rats were divided into four groups: adhesion-induced lexipafant, adhesion-induced saline, sham-operated lexipafant, and sham-operated saline.
- Peritoneal adhesions were induced via uterine horn scraping; lexipafant or saline was administered.
- Adhesion scoring, hydroxyproline content, and serum IL-6 levels were assessed on day 14.
Main Results:
- Adhesion scores were significantly lower in the lexipafant-treated group compared to saline controls (P < 0.001).
- Serum IL-6 levels were elevated in the saline-treated adhesion group (P < 0.05).
- Hydroxyproline content showed no significant differences across groups.
Conclusions:
- Lexipafant demonstrates a significant role in preventing peritoneal adhesion formation.
- The administration of lexipafant did not adversely affect wound healing in this model.